Sandra Aung

2.0k total citations
42 papers, 1.3k citations indexed

About

Sandra Aung is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Sandra Aung has authored 42 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 22 papers in Immunology and 9 papers in Molecular Biology. Recurrent topics in Sandra Aung's work include Cancer Immunotherapy and Biomarkers (21 papers), Immunotherapy and Immune Responses (14 papers) and Immune Cell Function and Interaction (12 papers). Sandra Aung is often cited by papers focused on Cancer Immunotherapy and Biomarkers (21 papers), Immunotherapy and Immune Responses (14 papers) and Immune Cell Function and Interaction (12 papers). Sandra Aung collaborates with scholars based in United States, France and Australia. Sandra Aung's co-authors include Linda A. Sherman, Barney S. Graham, Javier Hernández, William L. Redmond, Kristi Marquardt, Bernard A. Fox, Hong‐Ming Hu, Walter J. Urba, Yuhuan Li and John A. Rutigliano and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and Immunity.

In The Last Decade

Sandra Aung

42 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Aung United States 15 889 459 336 198 134 42 1.3k
Antonio Polley United States 5 1.5k 1.7× 883 1.9× 309 0.9× 177 0.9× 64 0.5× 5 1.9k
Angus T. Stock Australia 15 1.8k 2.0× 358 0.8× 301 0.9× 290 1.5× 81 0.6× 24 2.1k
David Ghez France 21 541 0.6× 395 0.9× 247 0.7× 241 1.2× 63 0.5× 81 1.4k
Christian A. Schmidt Germany 17 813 0.9× 434 0.9× 234 0.7× 214 1.1× 58 0.4× 47 1.5k
Hyun‐Tak Jin South Korea 10 592 0.7× 371 0.8× 235 0.7× 149 0.8× 36 0.3× 12 908
Carmela La Mendola Italy 13 1.2k 1.4× 702 1.5× 105 0.3× 167 0.8× 66 0.5× 19 1.5k
Tihui Fu United States 16 1.2k 1.4× 743 1.6× 170 0.5× 387 2.0× 58 0.4× 21 1.7k
Dan Suan Australia 11 606 0.7× 211 0.5× 154 0.5× 220 1.1× 54 0.4× 26 1.0k
Danielle L. Drayton United States 7 1.2k 1.4× 383 0.8× 123 0.4× 195 1.0× 56 0.4× 7 1.6k
Kristine Murphy United States 9 1.6k 1.8× 685 1.5× 146 0.4× 155 0.8× 49 0.4× 9 1.9k

Countries citing papers authored by Sandra Aung

Since Specialization
Citations

This map shows the geographic impact of Sandra Aung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Aung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Aung more than expected).

Fields of papers citing papers by Sandra Aung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Aung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Aung. The network helps show where Sandra Aung may publish in the future.

Co-authorship network of co-authors of Sandra Aung

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Aung. A scholar is included among the top collaborators of Sandra Aung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Aung. Sandra Aung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frentzas, Sophia, G. Thomas Budd, Catherine Shannon, et al.. (2024). Abstract PO1-04-01: Phase 1 dose escalation study of ARX788, a next-generation anti-HER2 antibody drug conjugate, in heavily pretreated breast cancer patients. Cancer Research. 84(9_Supplement). PO1–4. 3 indexed citations
2.
Bentebibel, Salah-Eddine, Michael E. Hurwitz, Chantale Bernatchez, et al.. (2019). A First-in-Human Study and Biomarker Analysis of NKTR-214, a Novel IL2Rβγ-Biased Cytokine, in Patients with Advanced or Metastatic Solid Tumors. Cancer Discovery. 9(6). 711–721. 169 indexed citations
3.
Ven, Rieneke van de, Traci Hilton, Hong‐Ming Hu, et al.. (2018). Autophagosome-based strategy to monitor apparent tumor-specific CD8 T cells in patients with prostate cancer. OncoImmunology. 7(12). e1466766–e1466766. 5 indexed citations
4.
Clark, Joseph I., Jatinder Singh, Marc S. Ernstoff, et al.. (2018). A multi-center phase II study of high dose interleukin-2 sequenced with vemurafenib in patients with BRAF-V600 mutation positive metastatic melanoma. Journal for ImmunoTherapy of Cancer. 6(1). 76–76. 13 indexed citations
5.
Vaena, Daniel A., Jorge Chaves, Nicholas J. Vogelzang, et al.. (2018). PROPEL: A phase 1/2 trial of NKTR-214 (CD122-biased agonist) combined with anti-PD-1 (pembrolizumab) or anti-PD-L1 (atezolizumab) in patients (pts) with advanced solid tumors.. Journal of Clinical Oncology. 36(15_suppl). TPS3115–TPS3115. 3 indexed citations
6.
7.
Diab, Adi, Nizar M. Tannir, Chantale Bernatchez, et al.. (2017). A phase 1/2 study of a novel IL-2 cytokine, NKTR-214, and nivolumab in patients with select locally advanced or metastatic solid tumors.. Journal of Clinical Oncology. 35(15_suppl). e14040–e14040. 9 indexed citations
8.
Sanborn, Rachel E., Brian C. Boulmay, Rui Li, et al.. (2017). P2.02-043 Randomized Ph II Trial of Allogeneic DPV-001 Cancer Vaccine Alone or with Adjuvant for Curatively-Treated Stage III NSCLC. Journal of Thoracic Oncology. 12(1). S873–S873. 2 indexed citations
9.
Morse, Michael A., Michael K.K. Wong, David F. McDermott, et al.. (2016). Durability of responses in patients with metastatic renal cell carcinoma treated with high-dose interleukin-2 (HD IL-2).. Journal of Clinical Oncology. 34(2_suppl). 511–511. 1 indexed citations
10.
Silk, Ann W., Joseph I. Clark, Gregory A. Daniels, et al.. (2015). Efficacy and safety of high-dose interleukin-2 treatment in patients with a history of brain metastases from renal cell carcinoma. Journal for ImmunoTherapy of Cancer. 3(S2). 1 indexed citations
11.
Wong, Michael K., Howard L. Kaufman, Gregory A. Daniels, et al.. (2014). Implementation of an Interleukin-2 National Registry: an opportunity to improve cancer outcomes. Journal for ImmunoTherapy of Cancer. 2(1). 20–20. 4 indexed citations
12.
Lowder, James N., Sandra Aung, Michael K. Wong, et al.. (2014). High-dose interleukin-2 registry, PROCLAIM: Modern data on toxicities and outcomes.. Journal of Clinical Oncology. 32(4_suppl). 430–430. 2 indexed citations
13.
Hilton, Traci, Tyler Hulett, Rieneke van de Ven, et al.. (2013). DPV-001 an autophagosome-enriched cancer vaccine in phase II clinical trials contains 25 putative cancer antigens, DAMPS, HSPS and agonists for TLR 2, 3, 4, 7 and 9. Journal for ImmunoTherapy of Cancer. 1(S1). 5 indexed citations
14.
Yi, Yongxiang, Shu Su, Yuan Fang, et al.. (2012). Autophagy-assisted antigen cross-presentation. OncoImmunology. 1(6). 976–978. 50 indexed citations
15.
Li, Yuhuan, Lixin Wang, Puiyi Pang, et al.. (2011). Tumor-Derived Autophagosome Vaccine: Mechanism of Cross-Presentation and Therapeutic Efficacy. Clinical Cancer Research. 17(22). 7047–7057. 115 indexed citations
16.
Li, Yuhuan, Lixin Wang, Puiyi Pang, et al.. (2009). Cross-presentation of tumor associated antigens through tumor-derived autophagosomes. Autophagy. 5(4). 576–577. 51 indexed citations
17.
Lyman, Michael A., Sandra Aung, J Biggs, & Linda A. Sherman. (2004). A Spontaneously Arising Pancreatic Tumor Does Not Promote the Differentiation of Naive CD8+ T Lymphocytes into Effector CTL. The Journal of Immunology. 172(11). 6558–6567. 65 indexed citations
18.
Rutigliano, John A., et al.. (2004). Treatment with Anti-LFA-1 Delays the CD8+Cytotoxic-T-Lymphocyte Response and Viral Clearance in Mice with Primary Respiratory Syncytial Virus Infection. Journal of Virology. 78(6). 3014–3023. 23 indexed citations
19.
Kreuwel, Huub T. C., et al.. (2002). Memory CD8+ T Cells Undergo Peripheral Tolerance. Immunity. 17(1). 73–81. 64 indexed citations
20.
Aung, Sandra, John A. Rutigliano, & Barney S. Graham. (2001). Alternative Mechanisms of Respiratory Syncytial Virus Clearance in Perforin Knockout Mice Lead to Enhanced Disease. Journal of Virology. 75(20). 9918–9924. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonio Polley Breakdown of academic impact, for papers by Angus T. Stock Breakdown of academic impact, for papers by David Ghez Breakdown of academic impact, for papers by Christian A. Schmidt Breakdown of academic impact, for papers by Hyun‐Tak Jin Breakdown of academic impact, for papers by Carmela La Mendola Breakdown of academic impact, for papers by Tihui Fu Breakdown of academic impact, for papers by Dan Suan Breakdown of academic impact, for papers by Danielle L. Drayton Breakdown of academic impact, for papers by Kristine Murphy
Rankless by CCL
2026